rare chromosome disorder support groupEstimated Valuation
£362.4k
Pomanda estimates the enterprise value of RARE CHROMOSOME DISORDER SUPPORT GROUP at £362.4k based on a Turnover of £396.7k and 0.91x industry multiple (adjusted for size and gross margin).
rare chromosome disorder support groupEstimated Valuation
£127.5k
Pomanda estimates the enterprise value of RARE CHROMOSOME DISORDER SUPPORT GROUP at £127.5k based on an EBITDA of £20.9k and a 6.11x industry multiple (adjusted for size and gross margin).
rare chromosome disorder support groupEstimated Valuation
£826.9k
Pomanda estimates the enterprise value of RARE CHROMOSOME DISORDER SUPPORT GROUP at £826.9k based on Net Assets of £337.8k and 2.45x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Rare Chromosome Disorder Support GroupOverview
Rare Chromosome Disorder Support Group is a live company located in oxted, RH8 9EE with a Companies House number of 05460413. It operates in the activities of other membership organizations n.e.c. sector, SIC Code 94990. Founded in May 2005, it's largest shareholder is
unknown.
Rare Chromosome Disorder Support Group is a mature,
micro sized company, Pomanda has estimated its turnover at
£396.7k with
low
growth in recent years.
Rare Chromosome Disorder Support Group Health Check
Pomanda's financial health check has awarded Rare Chromosome Disorder Support Group a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
5 Strong
3 Regular
3 Weak
Size
annual sales of £396.7k, make it in line with the average company (£418k)
£396.7k - Rare Chromosome Disorder Support Group
£418k - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (7.5%)
4% - Rare Chromosome Disorder Support Group
7.5% - Industry AVG
Production
with a gross margin of 87.6%, this company has a comparable cost of product (87.6%)
87.6% - Rare Chromosome Disorder Support Group
87.6% - Industry AVG
Profitability
an operating margin of 4.9% make it more profitable than the average company (1.5%)
4.9% - Rare Chromosome Disorder Support Group
1.5% - Industry AVG
Employees
with 6 employees, this is below the industry average (10)
6 - Rare Chromosome Disorder Support Group
10 - Industry AVG
Pay Structure
on an average salary of £45.5k, the company has a higher pay structure (£27k)
£45.5k - Rare Chromosome Disorder Support Group
£27k - Industry AVG
Efficiency
resulting in sales per employee of £66.1k, this is more efficient (£51.9k)
£66.1k - Rare Chromosome Disorder Support Group
£51.9k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (13 days)
0 days - Rare Chromosome Disorder Support Group
13 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Rare Chromosome Disorder Support Group
- - Industry AVG
Stock Days
it holds stock equivalent to 21 days, this is in line with average (22 days)
21 days - Rare Chromosome Disorder Support Group
22 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 1201 weeks, this is more cash available to meet short term requirements (161 weeks)
1201 weeks - Rare Chromosome Disorder Support Group
161 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 4%, this is a lower level of debt than the average (18.6%)
4% - Rare Chromosome Disorder Support Group
18.6% - Industry AVG
RARE CHROMOSOME DISORDER SUPPORT GROUP financials
EXPORT
Rare Chromosome Disorder Support Group's latest turnover from March 2024 is £396.7 thousand and the company has net assets of £337.8 thousand. According to their latest financial statements, Rare Chromosome Disorder Support Group has 6 employees and maintains cash reserves of £323.7 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Turnover
396,667
289,143
304,805
357,247
323,842
391,978
288,592
325,118
373,721
316,353
272,222
308,799
304,109
265,614
268,799
Other Income Or Grants
Cost Of Sales
49,086
32,528
18,133
19,079
17,306
15,153
21,941
31,035
177,102
152,328
139,183
167,613
163,001
146,021
139,984
Gross Profit
347,581
256,615
286,672
338,168
306,536
376,825
266,651
294,083
196,619
164,025
133,039
141,186
141,108
119,593
128,815
Admin Expenses
328,125
364,962
328,804
267,513
314,500
243,045
295,354
326,550
139,086
153,427
125,983
97,564
20,741
97,651
110,844
Operating Profit
19,456
-108,347
-42,132
70,655
-7,964
133,780
-28,703
-32,467
57,533
10,598
7,056
43,622
120,367
21,942
17,971
Interest Payable
Interest Receivable
Pre-Tax Profit
27,025
-93,420
-39,005
57,562
-7,585
110,345
-27,263
-31,756
46,977
9,361
6,530
34,173
89,816
16,282
13,173
Tax
Profit After Tax
27,025
-93,420
-39,005
57,562
-7,585
110,345
-27,263
-31,756
46,977
9,361
6,530
34,173
89,816
16,282
13,173
Dividends Paid
Retained Profit
27,025
-93,420
-39,005
57,562
-7,585
110,345
-27,263
-31,756
46,977
9,361
6,530
34,173
89,816
16,282
13,173
Employee Costs
272,816
294,446
249,217
243,720
233,560
196,073
197,847
207,386
193,668
186,956
168,647
155,708
148,035
134,796
134,726
Number Of Employees
6
7
7
7
7
6
6
9
9
6
5
5
5
4
4
EBITDA*
20,857
-106,496
-39,321
72,065
-6,150
137,725
-25,565
-28,980
60,791
11,572
8,514
45,102
121,792
23,187
19,017
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Tangible Assets
2,115
2,802
4,653
1,860
3,270
3,284
3,541
6,679
8,709
3,587
1,691
2,063
2,847
2,157
3,402
Intangible Assets
Investments & Other
4,000
4,000
700
700
700
700
700
700
700
700
700
700
700
700
700
Debtors (Due After 1 year)
749
Total Fixed Assets
6,115
6,802
5,353
2,560
3,970
3,984
4,241
7,379
9,409
5,036
2,391
2,763
3,547
2,857
4,102
Stock & work in progress
2,877
2,794
1,405
1,721
2,608
1,147
1,567
1,711
3,839
1,517
1,323
1,140
1,148
305
340
Trade Debtors
167
290
122
2,559
200
128
265
329
1,478
1,100
268
Group Debtors
Misc Debtors
18,989
11,479
16,234
19,675
7,636
16,473
12,829
7,673
7,779
8,067
7,879
7,399
11,162
16,508
8,067
Cash
323,663
307,847
394,606
439,284
378,719
380,244
272,703
305,863
274,437
245,043
303,202
273,403
263,555
139,011
129,894
misc current assets
55,605
55,000
total current assets
345,696
322,410
412,245
460,802
391,522
398,064
287,227
315,512
341,989
311,105
313,504
282,210
275,865
155,824
138,301
total assets
351,811
329,212
417,598
463,362
395,492
402,048
291,468
322,891
351,398
316,141
315,895
284,973
279,412
158,681
142,403
Bank overdraft
Bank loan
535
Trade Creditors
274
80
510
129
4,279
1,636
904
2,795
2,238
Group/Directors Accounts
other short term finances
194
274
3,128
hp & lease commitments
other current liabilities
14,009
18,161
16,621
23,460
13,152
11,613
11,888
15,725
8,246
19,755
32,195
6,447
35,616
6,939
6,943
total current liabilities
14,009
18,435
16,701
23,460
13,152
12,123
11,888
16,048
12,799
24,519
33,634
9,242
37,854
6,939
6,943
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
14,009
18,435
16,701
23,460
13,152
12,123
11,888
16,048
12,799
24,519
33,634
9,242
37,854
6,939
6,943
net assets
337,802
310,777
400,897
439,902
382,340
389,925
279,580
306,843
338,599
291,622
282,261
275,731
241,558
151,742
135,460
total shareholders funds
337,802
310,777
400,897
439,902
382,340
389,925
279,580
306,843
338,599
291,622
282,261
275,731
241,558
151,742
135,460
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Operating Activities
Operating Profit
19,456
-108,347
-42,132
70,655
-7,964
133,780
-28,703
-32,467
57,533
10,598
7,056
43,622
120,367
21,942
17,971
Depreciation
1,401
1,851
2,811
1,410
1,814
3,945
3,138
3,487
3,258
974
1,458
1,480
1,425
1,245
1,046
Amortisation
Tax
Stock
83
1,389
-316
-887
1,461
-420
-144
-2,128
2,322
194
183
-8
843
-35
340
Debtors
7,387
-4,465
-3,563
9,602
-6,478
3,716
5,019
-170
-2,186
1,315
1,312
-3,495
-5,346
8,441
8,067
Creditors
-274
194
80
-510
510
-129
-4,150
2,643
732
-1,891
557
2,238
Accruals and Deferred Income
-4,152
1,540
-6,839
10,308
1,539
-275
-3,837
7,479
-11,509
-12,440
25,748
-29,169
28,677
-4
6,943
Deferred Taxes & Provisions
Cash flow from operations
8,961
-101,686
-42,201
73,658
-104
134,664
-34,406
-23,353
51,789
-1,645
30,876
19,993
157,210
14,777
17,553
Investing Activities
capital expenditure
-714
-5,604
-1,800
-3,688
-1,457
-8,380
-2,870
-1,086
-696
-2,115
-4,448
Change in Investments
3,300
700
cash flow from investments
-714
-3,300
-5,604
-1,800
-3,688
-1,457
-8,380
-2,870
-1,086
-696
-2,115
-5,148
Financing Activities
Bank loans
-535
535
Group/Directors Accounts
Other Short Term Loans
-194
-80
-2,854
3,128
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
3,300
122,287
interest
cash flow from financing
3,300
-194
-80
-2,854
2,593
535
122,287
cash and cash equivalents
cash
15,816
-86,759
-44,678
60,565
-1,525
107,541
-33,160
31,426
29,394
-58,159
29,799
9,848
124,544
9,117
129,894
overdraft
change in cash
15,816
-86,759
-44,678
60,565
-1,525
107,541
-33,160
31,426
29,394
-58,159
29,799
9,848
124,544
9,117
129,894
rare chromosome disorder support group Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for rare chromosome disorder support group. Get real-time insights into rare chromosome disorder support group's credit score, group structure and payment trends.
Rare Chromosome Disorder Support Group Competitor Analysis
Perform a competitor analysis for rare chromosome disorder support group by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in RH8 area or any other competitors across 12 key performance metrics.
rare chromosome disorder support group Ownership
RARE CHROMOSOME DISORDER SUPPORT GROUP group structure
Rare Chromosome Disorder Support Group has no subsidiary companies.
Ultimate parent company
RARE CHROMOSOME DISORDER SUPPORT GROUP
05460413
RARE CHROMOSOME DISORDER SUPPORT GROUP Shareholders
The sole shareholder of Rare Chromosome Disorder Support Group is -.
-
-
rare chromosome disorder support group directors
Rare Chromosome Disorder Support Group currently has 8 directors.
The longest serving directors include
Ms Edna Knight (May 2005) and
Ms Sophie Sainty (Nov 2009).
rare chromosome disorder support group company details
company number
05460413
Type
Private Ltd By Guarantee w/o Share Cap
industry
94990 - Activities of other membership organisations n.e.c.
incorporation date
May 2005
age
20
incorporated
UK
ultimate parent company
None
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
unique rcd ltd (November 2005)
accountant
WILLIAM GUY BLAKE
auditor
-
address
f4, the stables, station road west, oxted, surrey, RH8 9EE
Bank
LLOYDS TSB BANK PLC
Legal Advisor
-
rare chromosome disorder support group Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to rare chromosome disorder support group.
rare chromosome disorder support group Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RARE CHROMOSOME DISORDER SUPPORT GROUP. This can take several minutes, an email will notify you when this has completed.
rare chromosome disorder support groupCompanies House Filings - See Documents
